Alto Neuroscience Inc.(ANRO:US)
Market Cap$769.06M
Key Metrics
Price$21.94
Revenue (TTM)$0
Holders Revenue (TTM)$5.41M
Gross Profit (TTM)-
Earnings (TTM)-$74.31M
EBITDA (TTM)-$71.22M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield0.7%
Cash on hand$263.76M
Total Assets$276.26M
Net Assets$243.37M
Total Debt$23.22M
Key Metrics
Price$21.94
Revenue (TTM)$0
Holders Revenue (TTM)$5.41M
Gross Profit (TTM)-
Earnings (TTM)-$74.31M
EBITDA (TTM)-$71.22M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield0.7%
Cash on hand$263.76M
Total Assets$276.26M
Net Assets$243.37M
Total Debt$23.22M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | - | $0 | - | - | - | $0 | - | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $27.14M | $17.06M | $14.95M | $18.68M | - | $17M | - | - | - | $11.77M | - | $9.13M | $7.2M | $8.03M | |
| Research and Development | $20.29M | $12M | $10.53M | $13.12M | - | $10.8M | - | - | - | $9.64M | - | $7.07M | $5.61M | $6.32M |
| Selling, General, and Administrative | $6.84M | $5.06M | $4.43M | $5.56M | - | $6.2M | - | - | - | $2.12M | - | $2.05M | $1.59M | $1.74M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | -$31K |
Operating Income | -$27.14M | -$17.06M | -$14.95M | -$18.68M | - | -$17M | - | - | - | -$11.77M | - | -$9.13M | -$7.2M | -$8.03M |
| $901K | $873K | $770K | $976K | - | $1.8M | - | - | - | $548K | - | $462K | -$83K | $377K | |
| Non-Operating Interest Income | $1.56M | $1.56M | $1.53M | $1.68M | - | $2.14M | - | - | - | $738K | - | $667K | $230K | $112K |
| Non-Operating Interest Expense | $545K | $575K | $650K | $646K | - | $333K | - | - | - | $356K | - | $327K | $324K | - |
| Other Income/Expense | -$115K | -$113K | -$112K | -$61K | - | -$6K | - | - | - | $166K | - | $122K | $11K | $265K |
Income Before Tax | -$26.24M | -$16.18M | -$14.18M | -$17.71M | - | -$15.2M | - | - | - | -$11.22M | - | -$8.66M | -$7.28M | -$7.65M |
Income Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -$26.24M | -$16.18M | -$14.18M | -$17.71M | - | -$15.2M | - | - | - | -$11.22M | - | -$8.66M | -$7.28M | -$7.65M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$26.24M | -$16.18M | -$14.18M | -$17.71M | - | -$15.2M | - | - | - | -$11.22M | - | -$8.66M | -$7.28M | -$7.65M |
Shares Outstanding (Basic) | 32.89M | - | 27.1M | 27.07M | 27.05M | - | 26.96M | 26.91M | 17.6M | - | 25.57M | 25.57M | 12.98M | - |
Shares Outstanding (Diluted) | 32.89M | - | 27.1M | 27.07M | 27.05M | - | 26.96M | 26.91M | 17.6M | - | 25.57M | 25.57M | 12.98M | - |
EPS (Basic) | -$0.80 | - | -$0.52 | -$0.65 | -$0.56 | - | -$0.62 | -$0.60 | -$0.76 | - | -$0.36 | -$0.34 | -$0.56 | - |
EPS (Diluted) | -$0.80 | - | -$0.52 | -$0.65 | -$0.56 | - | -$0.62 | -$0.60 | -$0.76 | - | -$0.36 | -$0.34 | -$0.56 | - |
EBIT | -$25.69M | -$15.61M | -$13.53M | -$17.06M | - | -$14.87M | - | - | - | -$10.86M | - | -$8.34M | -$6.96M | -$7.4M |
EBITDA | -$25.51M | -$15.45M | -$13.37M | -$16.89M | - | -$14.7M | - | - | - | -$10.94M | - | -$8.35M | -$6.89M | -$7.57M |